Leading events organiser UBM Live today announced the launch of two new brands, InnoPack and LabWorld, which will be co-located alongside its flagship portfolio of pharma events, CPhI Worldwide for ingredients; ICSE for contract services; P-MEC Europe for equipment, machinery and technology; and BioPh Europe for biopharma, which draw an attendance of over 25,000 annually.
Both InnoPack and LAB (Laboratory, Analytical & Biotechology) World will make their debuts in 2011, when the group of events takes place at Messe Frankfurt, Germany, from 25th-27th October.
Launched to offer the Pharma community innovative and diverse packaging solutions to satisfy the changing ways in which medication is packaged and delivered, InnoPack reflects an organic evolution from the ICSE Packaging Zone, which was introduced successfully at the 2010 event in Paris and hosted over 50 first time packaging exhibitors.
The introduction of the new event is designed to match the needs of a pharmaceutical packaging market that is forecast to grow at a dynamic pace due to both the maturing Biopharmaceuticals sector and as companies increasingly look for new and innovative methods to deliver drugs to the end user.
“The Global Pharmaceutical Packaging Market is forecast to grow at a CAGR of 6.9% between 2008 and 2015, reaching an estimated value of $68 billion by 2015,*” commented Haf Cennydd, Brand Director, UBM Live.
“InnoPack will create a forum via which senior executives can network and exchange the latest information on innovations across every aspect of pharmaceutical packaging, from materials and design to finished packaging and drug delivery. The new event will capitalise upon the synergies that already exist between our co-located events, and will benefit from the fact that they regularly attract over 1,900 exhibitors, have a visitor profile from over 125 countries and an audience of over 25,000 industry professionals.”
UBM’s second new Pharma brand for 2011, LABWorld was borne out of the significant diversification seen in exhibitor demographics at its global P-MEC events which, over the last two years, have witnessed rapid growth in the number of participants focused on high technology areas such as instrumental analysis, measuring and testing technologies, materials testing, quality control and laboratory equipment. LabWorld will target these areas as a separate brand to differentiate its exhibitors from the ‘traditional’ large-scale capital machinery with which P-MEC has become associated.
Cennydd continues: “Covering the laboratory, analytical and biotech equipment markets, LABWorld will cater for the increasingly sophisticated new technologies in the pharma and biopharma laboratory space and complements our existing co-located events. We envisage strong growth for the brand, particularly in our Asian markets where the majority of these technologies originate.”
UBM Live
www.ubm.com
